Stephen George Dilly - Net Worth and Insider Trading
Stephen George Dilly Net Worth
The estimated net worth of Stephen George Dilly is at least $18 Million dollars as of 2024-12-28. Stephen George Dilly is the President and CEO of Aimmune Therapeutics Inc and owns about 447,008 shares of Aimmune Therapeutics Inc (AIMT) stock worth over $15 Million. Stephen George Dilly is the See Remarks of Codexis Inc and owns about 438,878 shares of Codexis Inc (CDXS) stock worth over $2 Million. Stephen George Dilly is also the CEO and President of Sierra Oncology Inc and owns about 5,000 shares of Sierra Oncology Inc (SRRA) stock worth over $274,950. Besides these, Stephen George Dilly also holds Sangamo Therapeutics Inc (SGMO) . Details can be seen in Stephen George Dilly's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Stephen George Dilly has not made any transactions after 2023-09-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Stephen George Dilly
Stephen George Dilly Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Stephen George Dilly owns 4 companies in total, including Codexis Inc (CDXS) , Sierra Oncology Inc (SRRA) , and Sangamo Therapeutics Inc (SGMO) among others .
Click here to see the complete history of Stephen George Dilly’s form 4 insider trades.
Insider Ownership Summary of Stephen George Dilly
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CDXS | Codexis Inc | 2023-09-08 | director & See Remarks |
| SRRA | Sierra Oncology Inc | 2021-05-19 | director & CEO and President |
| SGMO | Sangamo Therapeutics Inc | 2020-03-19 | director |
 | | 2018-06-11 | director & President and CEO |
Stephen George Dilly Latest Holdings Summary
Stephen George Dilly currently owns a total of 4 stocks. Among these stocks, Stephen George Dilly owns 447,008 shares of Aimmune Therapeutics Inc (AIMT) as of June 11, 2018, with a value of $15 Million and a weighting of 86.15%. Stephen George Dilly owns 438,878 shares of Codexis Inc (CDXS) as of September 8, 2023, with a value of $2 Million and a weighting of 12.24%. Stephen George Dilly also owns 5,000 shares of Sierra Oncology Inc (SRRA) as of May 19, 2021, with a value of $274,950 and a weighting of 1.54%. The other 1 stocks Sangamo Therapeutics Inc (SGMO) have a combined weighting of 0.07% among all his current holdings.
Latest Holdings of Stephen George Dilly
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AIMT | Aimmune Therapeutics Inc | 2018-06-11 | 447,008 | 34.49 | 15,417,306 |
| CDXS | Codexis Inc | 2023-09-08 | 438,878 | 4.99 | 2,190,001 |
| SRRA | Sierra Oncology Inc | 2021-05-19 | 5,000 | 54.99 | 274,950 |
| SGMO | Sangamo Therapeutics Inc | 2020-03-19 | 5,000 | 2.56 | 12,800 |
Holding Weightings of Stephen George Dilly
Stephen George Dilly Form 4 Trading Tracker
According to the SEC Form 4 filings, Stephen George Dilly has made a total of 0 transactions in Aimmune Therapeutics Inc (AIMT) over the past 5 years. The most-recent trade in Aimmune Therapeutics Inc is the sale of 29,457 shares on June 11, 2018, which brought Stephen George Dilly around $908,159.
According to the SEC Form 4 filings, Stephen George Dilly has made a total of 2 transactions in Codexis Inc (CDXS) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Codexis Inc is the acquisition of 58,479 shares on September 8, 2023, which cost Stephen George Dilly around $101,169.
According to the SEC Form 4 filings, Stephen George Dilly has made a total of 1 transactions in Sierra Oncology Inc (SRRA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Sierra Oncology Inc is the acquisition of 5,000 shares on May 19, 2021, which cost Stephen George Dilly around $89,150.
More details on Stephen George Dilly's insider transactions can be found in the Insider Trading History of Stephen George Dilly table.Insider Trading History of Stephen George Dilly
- 1
Stephen George Dilly Trading Performance
GuruFocus tracks the stock performance after each of Stephen George Dilly's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Stephen George Dilly is 25.71%. GuruFocus also compares Stephen George Dilly's trading performance to market benchmark return within the same time period. The performance of stocks bought by Stephen George Dilly within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Stephen George Dilly's insider trading performs compared to the benchmark.
Performance of Stephen George Dilly
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 11.45 | | | | | |
| Relative Return to S&P 500(%) | 12.5 | | | | | |
Stephen George Dilly Ownership Network
Stephen George Dilly Owned Company Details
What does Codexis Inc do?
Who are the key executives at Codexis Inc?
Stephen George Dilly is the director & See Remarks of Codexis Inc. Other key executives at Codexis Inc include Chief Operating Officer Kevin Norrett , See Remarks Margaret Nell Fitzgerald , and Chief Financial Officer Sriram Ryali .
Codexis Inc (CDXS) Insider Trades Summary
Over the past 18 months, Stephen George Dilly made 1 insider transaction in Codexis Inc (CDXS) with a net purchase of 58,479. Other recent insider transactions involving Codexis Inc (CDXS) include a net purchase of 1,271,000 shares made by Opaleye Management Inc. , a net sale of 20,000 shares made by Byron L Dorgan , and a net purchase of 11,834 shares made by Margaret Nell Fitzgerald .
In summary, during the past 3 months, insiders sold 0 shares of Codexis Inc (CDXS) in total and bought 25,000 shares, with a net purchase of 25,000 shares. During the past 18 months, 20,000 shares of Codexis Inc (CDXS) were sold and 1,361,963 shares were bought by its insiders, resulting in a net purchase of 1,341,963 shares.
Codexis Inc (CDXS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Codexis Inc Insider Transactions
Stephen George Dilly Mailing Address
Above is the net worth, insider trading, and ownership report for Stephen George Dilly. You might contact Stephen George Dilly via mailing address: C/o Sierra Oncology, Inc., 1820 Gateway Drive, Suite 110, San Mateo Ca 94404.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
